Rebetol Sales Begin in France, ICN Says
Dow Jones
Costa Mesa drug maker ICN Pharmaceuticals Inc. said Wednesday that sales of Rebetol to treat the highly contagious and potentially fatal hepatitis C liver disease have begun in France.
ICN said that Schering-Plough Corp., which licenses ICN’s ribavirin antiviral drug as part of the treatment, also is selling Rebetol in Spain, Germany, Italy and the United Kingdom.
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.
